{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:00:35Z","timestamp":1776970835308,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00c3\u00a7\u00c3\u00a3o de Aperfei\u00c3\u00a7oamento de Pessoal de N\u00c3\u00advel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Amparo \u00c3\u00a0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00c3\u00adfico e Tecnol\u00c3\u00b3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Amparo \u00c3\u00a0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["EDITAL 04\/2016 \u2013 PRONUPEQ 2016"],"award-info":[{"award-number":["EDITAL 04\/2016 \u2013 PRONUPEQ 2016"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00c3\u00adfico e Tecnol\u00c3\u00b3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mycmed.2020.100938","type":"journal-article","created":{"date-parts":[[2020,2,9]],"date-time":"2020-02-09T09:31:03Z","timestamp":1581240663000},"page":"100938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ex vivo nail infection as an effective preclinical method for screening of new topical antifungals"],"prefix":"10.1016","volume":"30","author":[{"given":"P.M.","family":"Quatrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.F.A.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Berlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.C.K.","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.F.S.","family":"Canto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Fuentefria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2020.100938_bib0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/myc.12592","article-title":"Understanding the formidable nail barrier: a review of the nail microstructure, composition and diseases","volume":"60","author":"Baswan","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100938_bib0170","first-page":"762","article-title":"Onychomycosis: current trends in diagnosis and treatment","volume":"88","author":"Westerberg","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.mycmed.2020.100938_bib0175","first-page":"1","article-title":"Global perspectives for the management of onychomycosis","volume":"57","author":"Gupta","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/13543784.2016.1142529","article-title":"Novel investigational therapies for onychomycosis: an update","volume":"25","author":"Gupta","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mycmed.2020.100938_bib0185","first-page":"CD010031","article-title":"Oral antifungal medication for toenail onychomycosis","volume":"7","author":"Kreijkamp-Kaspers","year":"2017","journal-title":"Cochrane Database Syst"},{"key":"10.1016\/j.mycmed.2020.100938_bib0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073086","article-title":"Treatment failures and relapses in onychomycosis: a stubborn clinical problem","volume":"207","author":"Arrese","year":"2003","journal-title":"Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2014008464","article-title":"Drug delivery to the nail: therapeutic options and challenges for onychomycosis","volume":"31","author":"Barot","year":"2014","journal-title":"Crit Rev Ther Drug Carr Syst"},{"key":"10.1016\/j.mycmed.2020.100938_bib0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40257-014-0096-2","article-title":"Topical therapy for toenail onychomycosis: an evidence-based review","volume":"15","author":"Gupta","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/1346-8138.14935","article-title":"Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: a multicenter, single-arm study","volume":"8","author":"Iozumi","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0210","first-page":"190","article-title":"Tavaborole 5% topical solution for the treatment of toenail onychomycosis in pediatric patients: results from a phase 4 open-label study","volume":"18","author":"Rich","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0215","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02117-18","article-title":"Improved methods for assessing therapeutic potential of antifungal agents against dermatophytes and their application in the development of NP213, a novel onychomycosis therapy candidate","volume":"63","author":"Mercer","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100938_bib0220","doi-asserted-by":"crossref","DOI":"10.3390\/jof3040058","article-title":"Fungicidal activity in the presence of keratin as na important factor contributing to in vivo efficacy: a comparison of Efinaconazole, Tavaborole, and Ciclopirox","volume":"3","author":"Tachibana","year":"2017","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2020.100938_bib0225","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2133.2008.08549.x","article-title":"Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis","volume":"158","author":"Dai","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0230","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1039\/C8NJ04935A","article-title":"3-Selenocyanate-indoles as new agents to the treatment of superficial and mucocutaneous infections","volume":"43","author":"Quatrin","year":"2019","journal-title":"New J Chem"},{"key":"10.1016\/j.mycmed.2020.100938_bib0235","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpb.2013.01.015","article-title":"Infected nail plate model made of human hair keratin for evaluating the efficacy of diferente topical antifungal formulations against Trichophyton rubrum in vitro","volume":"84","author":"Lusiana","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.mycmed.2020.100938_bib0240","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1469-7580.2009.01066.x","article-title":"Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia","volume":"214","author":"Bragulla","year":"2009","journal-title":"J Anat"},{"key":"10.1016\/j.mycmed.2020.100938_bib0245","first-page":"1025","article-title":"Histological structure of human nail as studied by synchotron X-ray microdiffraction","volume":"46","author":"Garson","year":"2000","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0250","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1099\/jmm.0.46542-0","article-title":"Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)","volume":"56","author":"da Silva Barros","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0255","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/AAC.04842-14","article-title":"Ability of hydroxypropyl chitosan nail lacquer to protect against dermatophyte nail infection","volume":"59","author":"Ghannoum","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100938_bib0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4155\/tde-2017-0069","article-title":"Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation","volume":"9","author":"Thatai","year":"2018","journal-title":"Ther Deliv"},{"key":"10.1016\/j.mycmed.2020.100938_bib0265","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1021\/mp400711q","article-title":"Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model","volume":"11","author":"T\u00e4uber","year":"2014","journal-title":"Mol Pharmaceutics"},{"key":"10.1016\/j.mycmed.2020.100938_bib0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mimet.2015.03.009","article-title":"Development of a novel in vitro onychomycosis model for the evaluation of topical antifungal activity","volume":"112","author":"Sleven","year":"2015","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.mycmed.2020.100938_bib0275","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/myc.12475","article-title":"Evaluation of topical antifungal products in an in vitro onychomycosis model","volume":"59","author":"Sleven","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100938_bib0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000448056","article-title":"Onychomycosis: practical approaches to minimize relapse and recurrence","volume":"2","author":"Tosti","year":"2016","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.mycmed.2020.100938_bib0285","first-page":"E16","article-title":"Over-the-counter and natural remedies for onychomycosis: do they really work?","volume":"98","author":"Halteh","year":"2016","journal-title":"Cutis"},{"key":"10.1016\/j.mycmed.2020.100938_bib0290","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jaad.2016.01.008","article-title":"The role of biofilms in onychomycosis","volume":"74","author":"Gupta","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1439-0507.2007.01445.x","article-title":"An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents","volume":"51","author":"Ohnemus","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100938_bib0300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fvets.2018.00164","article-title":"The use of ex vivo rodent platforms in neuroscience translational research with attention to the 3Rs philosophy","volume":"5","author":"Lossi","year":"2018","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.mycmed.2020.100938_bib0305","doi-asserted-by":"crossref","first-page":"125384","DOI":"10.1155\/2012\/125384","article-title":"Animal model of dermatophytosis","volume":"2012","author":"Shimamura","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0310","first-page":"10","article-title":"The role of topical antifungal therapy for onychomycosis and the emergence of newer agents","volume":"7","author":"del Rosso","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.mycmed.2020.100938_bib0315","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2014.02.013","article-title":"Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems","volume":"180","author":"Naumann","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.mycmed.2020.100938_bib0320","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ics.12142","article-title":"Transungual delivery: deliberations and creeds","volume":"36","author":"Thatai","year":"2014","journal-title":"Int J Cosmet Sci"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319302975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319302975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:20:21Z","timestamp":1761110421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523319302975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1156523319302975"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.100938","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo nail infection as an effective preclinical method for screening of new topical antifungals","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.100938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100938"}}